IGFBP2 and obesity due to melanocortin 4 receptor deficiency: The relationship between IGFBP2 and body weight has been reported in patients with anorexia nervosa or cancer linked malnutrition who have elevated circulating levels while low levels are demonstrated in obesity, metabolic syndrome, type 2 diabetes, and that administration of IGFBP2 can prevent adipogenesis52–55.